Florida’s Drug Importation Plan Gains FDA Approval: What’s Next?

Partner Libby Baney, director Elliot Vice, analyst Maya Bolter and senior manager Nisha Quasba co-authored an article for Innovations Magazine on the first ever Section 804 Importation Program (SIP) application approved by the FDA that aims to allow states to bulk import prescription drugs from Canada.

The article explores details of Florida’s SIP, including logistical details, anticipated timeline for implementation, and the program’s susceptibility to misinformation and misunderstanding. Despite challenges such as supply chain security risks, Florida’s approval not only sets a precedent for other states but also serves as a blueprint for future state applications.